申请人:The Dow Chemical Company
公开号:US04105791A1
公开(公告)日:1978-08-08
The present invention relates to novel monocyclic and polycyclic p-cycloalkylaminobenzoic acids, the corresponding pharmaceutically-acceptable salts and the esters thereof. This invention also relates to methods for reducing plasma lipid levels, especially cholesterol and triglyceride levels, using the compounds of the present invention.
本发明涉及新颖的单环和多环p-环烷基氨基苯甲酸,其相应的药用盐及其酯。本发明还涉及使用本发明化合物降低血浆脂质水平,特别是胆固醇和甘油三酯水平的方法。